Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model
dc.contributor.author | Rico, María José | |
dc.contributor.author | Rozados, Viviana R. | |
dc.contributor.author | Mainetti, Leandro Ernesto | |
dc.contributor.author | Zacarías Fluck, Mariano | |
dc.contributor.author | Matar, Pablo | |
dc.contributor.author | Scharovsky, O. Graciela | |
dc.date.accessioned | 2012-08-24T14:59:09Z | |
dc.date.available | 2012-08-24T14:59:09Z | |
dc.date.issued | 2012-03 | |
dc.description.abstract | Aim: Experimental and clinical studies showed that the administration of cyclophosphamide (Cy) in low doses leads to an enhancement of the antitumor immune response. Our objective was to study the modulation, if any, by low dose Cy, of T regulatory (Treg) and natural killer T (NKT) I cells, two cell populations of the innate immune response with opposing effects on the tumors, in a rat B cell lymphoma model. Methods: Inbred e rats were challenged s.c. with L-TACB lymphoma and on day 14 animals were distributed in two groups. Treated: injected i.p. with cyclophosphamide (10mg/kg of body weight) and Control: injected i.p. with saline. Blood samples were taken from days 0 to 21 and the percentage of T regulatory and natural killer T I cells were determined by flow cytometry. Results: We found that the increase of natural and inducible T regulatory cells of peripheral blood achieved during tumor growth was significantly downregulated by cyclophosphamide. On the contrary, natural killer T I cells were not modulated by the treatment. Conclusion: The antimetastatic effect of a single low dose of Cy would be due, at least in part, to downregulation of natural and inducible T regulatory cells. | es |
dc.description.peerreviewed | Peer reviewed | es |
dc.description.sponsorship | Cibic S.A. This work was supported by a grant from Universidad Nacional de Rosario to O.G. Scharovsky. | es |
dc.format | application/pdf | |
dc.identifier.issn | 1812-9269 | |
dc.identifier.uri | http://hdl.handle.net/2133/2006 | |
dc.language.iso | en | es |
dc.publisher | MORION LLC | es |
dc.rights | openAccess | |
dc.rights.text | © Experimental Oncology, 2012 | es |
dc.subject | T regulatory cells | es |
dc.subject | NKT I cells | es |
dc.subject | cyclophosphamide | es |
dc.subject | lymphoma | es |
dc.subject.mesh | Animals | |
dc.subject.mesh | Antineoplastic Agents, Alkylating/administration & dosage | |
dc.subject.mesh | Cyclophosphamide/administration & dosage | |
dc.subject.mesh | Disease Models, Animal | |
dc.subject.mesh | Female | |
dc.subject.mesh | Lymphoma, B-Cell/drug therapy | |
dc.subject.mesh | Lymphoma, B-Cell/immunology | |
dc.subject.mesh | Natural Killer T-Cells/immunology | |
dc.subject.mesh | Rats | |
dc.subject.mesh | T-Lymphocytes, Regulatory/drug effects | |
dc.subject.mesh | T-Lymphocytes, Regulatory/immunology | |
dc.title | Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model | es |
dc.type | article | |
dc.type | artículo | |
dc.type | publishedVersion |
Archivos
Bloque original
1 - 1 de 1
Cargando...
- Nombre:
- Regulatory T cells but not NKT I cells are modulated by a single low-dose cyclophosphamide in a B cell lymphoma tumor-model.pdf
- Tamaño:
- 108.02 KB
- Formato:
- Adobe Portable Document Format
Bloque de licencias
1 - 1 de 1
- Nombre:
- license.txt
- Tamaño:
- 0 B
- Formato:
- Item-specific license agreed upon to submission
- Descripción: